Evonik Industries AG (EVKIY)
| Market Cap | 8.85B -0.3% |
| Revenue (ttm) | 16.52B -7.2% |
| Net Income | 744.39M +185.6% |
| EPS | 1.60 +185.5% |
| Shares Out | n/a |
| PE Ratio | 11.89 |
| Forward PE | 13.17 |
| Dividend | 0.44 (5.02%) |
| Ex-Dividend Date | May 30, 2025 |
| Volume | 400 |
| Average Volume | 4,817 |
| Open | 9.50 |
| Previous Close | 9.37 |
| Day's Range | 9.50 - 9.60 |
| 52-Week Range | 7.24 - 12.33 |
| Beta | 0.71 |
| RSI | 75.74 |
| Earnings Date | Mar 4, 2026 |
About Evonik Industries AG
Evonik Industries AG produces and sells specialty chemicals in the Asia-Pacific, Europe, the Middle East, Africa, Central and South America, and North America. It operates through Specialty Additives, Nutrition & Care, Smart Materials, and Technology & Infrastructure segments. The Specialty Additives segment offers additives for polyurethane foams; additives, matting agents, fumed silicas, and specialty resins for paints, coatings, and printing inks; isophorone and epoxy curing agents for coatings, adhesives, and composites; and pour-point depr... [Read more]
Financial Performance
In 2025, Evonik Industries AG's revenue was 14.07 billion, a decrease of -7.18% compared to the previous year's 15.16 billion. Earnings were 634.00 million, an increase of 185.59%.
Financial numbers in EUR Financial StatementsNews
Evonik Industries AG (EVKIY) Q4 2025 Earnings Call Transcript
Evonik Industries AG (EVKIY) Q4 2025 Earnings Call February 4, 2026 7:00 PM ESTCompany ParticipantsChristian Kullmann - CEO & Chairman of the Executive...
Silicone Market worth $33,246.3 Million by 2030, at a CAGR of 5.2%, says MarketsandMarkets™
Delray Beach, FL, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The Silicone Market was worth USD 24,502.4 million in 2024 and is projected to reach USD 33,246.3 million by 2030, at a CAGR of 5.2%, as per the rec...
Global Feed Vitamins Market: Growth Outlook, Trends, and Strategic Insights
Delray Beach, FL, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The global feed vitamins market is set for steady expansion, reflecting the livestock industry's growing emphasis on balanced, science-based animal ...
SINTX (SINT) Partners with Evonik to Enhance Implant Manufacturing
SINTX (SINT) Partners with Evonik to Enhance Implant Manufacturing
Evonik Industries AG (EVKIY) Q3 2025 Earnings Call Transcript
Evonik Industries AG 2025 Q3 - Results - Earnings Call Presentation
Evonik Q3 Adj. EBITDA Declines
(RTTNews) - Evonik (EVK.DE) posted a third quarter net loss of 106 million euros compared to net income of 223 million euros, last year. Adjusted net income declined to 128 million euros from 271 mill...
Silicone Market worth $33,246.3 million by 2030, at a CAGR of 5.2%, says MarketsandMarkets™
Delray Beach, FL, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The Silicone Market was worth USD 24,502.4 million in 2024 and is projected to reach USD 33,246.3 million by 2030, at a CAGR of 5.2%, as per the rec...
Tire Market to Reach USD 462.9 billion by 2032, Growing At An 4.34% CAGR - Credence Research
PUNE, India , Oct. 15, 2025 /PRNewswire/ -- Market Overview The global tire market is experiencing robust expansion, driven by rising vehicle production, infrastructure development, and evolving consu...
Evonik: Revised Outlook Necessitates A Q3 2025 Update
Evonik Sees Persistently Weak Demand Until Year-end; Adjusts FY25 Outlook
(RTTNews) - Evonik Industries AG has adjusted the outlook for fiscal 2025. For 2025, Evonik had previously expected adjusted EBITDA to be between 2.0 billion and 2.3 billion euros, with the company mo...
Look Beyond The Volatility In Evonik Industries
Evonik Industries reports Q2 results
Evonik Industries AG (EVKIF) Q2 2025 Earnings Call Transcript
Evonik Industries AG 2025 Q2 - Results - Earnings Call Presentation
Evonik Industries AG (EVKIF) Q1 2025 Earnings Call Transcript
Evonik Industries AG (OTCPK:EVKIF) Q1 2025 Results Conference Call May 12, 2025 5:00 AM ETCompany ParticipantsChristian Kullmann - Chairman of the Executive...
Evonik Industries reports Q1 results
Evonik: Decent Rate Of Return, Upside Confirmed
Evonik Industries AG (EVKIF) Q4 2024 Earnings Call Transcript
Evonik Industries reports Q4 results; initiates Q1 and FY25 outlook
Silexion Therapeutics collaborates with Evonik on advanced siRNA Formulation Development
Cayman Islands, December 17, 2024 – Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven can...
